Research Topic · Peer-Reviewed

Alzheimer's Disease Trial

Alzheimer's Disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and eventually the ability to carry out the simplest tasks. It is the most common cause of dementia, the decline in cognitive functioning which affects one in 10 people over the age of 65, and one in t…

Curated from this journal's research 📚 3 peer-reviewed articles cited Cited 5× across the literature 🔖 ISSN 2998-4211 🗓 Reviewed July 2026

Overview

Alzheimer's Disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and eventually the ability to carry out the simplest tasks. It is the most common cause of dementia, the decline in cognitive functioning which affects one in 10 people over the age of 65, and one in three people over 85. Trial treatments are aimed at temporarily relieving symptoms and slowing the rate of decline. Research has shown that medications, lifestyle choices, and therapies can all improve symptoms, slow disease progression and improve quality of life for Alzheimer's patients. Clinical trials are an important part of the process of finding and developing new treatments. By participating in clinical trials, Alzheimer's patients and their families in the medical community can help create a better future for themselves and others.

Research published in this journal

3 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2017

JALR. New Journal, Old questions, Fresh insights

Paganelli RobertoCorresponding author
Department of Medicine & Sciences of Aging, University “G. d’Annunzio” of Chieti-Pescara, Italy
Alzheimer's Research and Therapy doi:10.14302/issn.2998-4211.jalr-17-1884

How this research is being cited

The 3 articles above have been cited 5 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Alzheimer's Disease Trial, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Alzheimer's Research and Therapy (ISSN 2998-4211).

Journal editorial board
Aysun Cetinyurek Yavuz · Netherlands Elvis Freeman Acquah · Australia Silvia Ingala · Denmark

This page summarises published research for orientation; it is not medical or professional advice.